FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aarti Drugs Buyback 2023 and BSE Buyback July 2023.
Aarti Drugs Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while BSE Buyback July 2023 is a Tender Offer proposed to list at NSE.
Aarti Drugs Limited | BSE Limited | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
Listing At | BSE, NSE | NSE | ||||||||||||||||||
Face Value | ₹10 per share | ₹2 per share | ||||||||||||||||||
Buyback Price | ₹900 per share | ₹1080 per share | ||||||||||||||||||
Issue Size | 6,65,000 shares | 34,70,370 shares | ||||||||||||||||||
Issue Size (Amount) | ₹59.85 Crores | ₹374.80 Crores | ||||||||||||||||||
Buyback Ratio |
|
|
||||||||||||||||||
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited | ||||||||||||||||||
Lead Managers | Inga Ventures Pvt Ltd | Nuvama Wealth Management Limited | ||||||||||||||||||
Necessity of the buyback | The Buy Back is being proposed by the Company to fulfill the following objectives:
|
The proposed Buy-back will help the Company achieve the following objectives:
|
Aarti Drugs Buyback 2023 and BSE Buyback July 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2023 Buyback record date is Aug 04, 2023. BSE Buyback July 2023 Buyback record date is Sep 14, 2023.
Aarti Drugs Limited | BSE Limited | |
---|---|---|
Record Date | Aug 04, 2023 | Sep 14, 2023 |
Offer Open Date | Aug 09, 2023 | Sep 21, 2023 |
Offer Closure Date | Aug 17, 2023 | Sep 27, 2023 |
Last date for receipt of tender forms | Aug 17, 2023 | Sep 27, 2023 |
Finalisation of buyback | Aug 23, 2023 | Oct 04, 2023 |
Last Date for settlment of bids | Aug 24, 2023 | Oct 05, 2023 |
Last Date for extinguishment of shares | Sep 04, 2023 | Oct 16, 2023 |
Comparison of Aarti Drugs Buyback 2023 and BSE Buyback July 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aarti Drugs Limited | BSE Limited | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Crore |
Amount in ₹ Crore |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|